About Quay Pharma

Established in 2002 by Professor Mike Rubinstein, Quay Pharma is an independent, privately owned company with the scientific...

Read more


Preclinical formulation and analysis of Active Pharmaceutical Ingredients (APIs), including those that present particular challenges...

Read More

Laboratory Facilities

We operate from three sites, two are 15km apart, one in England and the other, our head office Quay House, in North Wales. We have just opened...

Read More

Formulation Development

In-house capabilities offered, and is especially valuable where drugs show poor solubility or bioavailability, or require modified or targeted...

Read more

Live Biotherapeutics

Experienced in formulation development, currently one of the few companies licensed for the clinical manufacture of live...

Read More

Phase 1 Clinical Trials

All of the services required to bring an API into clinical use in the fastest and most cost-effective way, including unique Fast Track into Man...

Read More

Analytical Services

Analytical and quality control services, inc analytical method development and validation, and accelerated, formal and...

Read More

Phase 11/111 Clinical Trials

GMP clinical manufacturing services covering Phase I formulations, large-scale Phase II, Phase III and post-marketing studies...

Read More

Appearing Next at:

CPhI Worldwide

09th Oct 2018 to 11th Oct 2018

Find Out More


Interested in a career at Quay Pharma? We are always on the look out for the best in our field.

Contact Us


We are one of the world's leading contract, development, manufacturing and packaging organisations.

Contact Us